Insider Selling: Steris PLC (NYSE:STE) VP Sells 1,387 Shares of Stock

Steris PLC (NYSE:STE) VP Karen L. Burton sold 1,387 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $133.89, for a total transaction of $185,705.43. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

NYSE STE traded up $2.34 during trading hours on Friday, hitting $148.88. The company’s stock had a trading volume of 920,481 shares, compared to its average volume of 482,163. Steris PLC has a 52 week low of $99.14 and a 52 week high of $148.88. The stock has a market capitalization of $12.29 billion, a P/E ratio of 30.45 and a beta of 0.96. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.27 and a quick ratio of 1.82. The company’s 50-day moving average price is $137.19.

Steris (NYSE:STE) last announced its quarterly earnings results on Monday, May 13th. The medical equipment provider reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.44 by $0.09. The business had revenue of $768.00 million for the quarter, compared to analysts’ expectations of $738.87 million. Steris had a net margin of 10.93% and a return on equity of 13.34%. The firm’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.24 EPS. On average, research analysts anticipate that Steris PLC will post 5.37 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Wednesday, June 12th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Tuesday, June 11th. This represents a $1.36 annualized dividend and a yield of 0.91%. Steris’s dividend payout ratio (DPR) is 27.81%.

A number of large investors have recently bought and sold shares of STE. Oregon Public Employees Retirement Fund increased its stake in Steris by 10,585.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 3,572,743 shares of the medical equipment provider’s stock valued at $33,000 after buying an additional 3,539,306 shares during the last quarter. Norges Bank purchased a new stake in Steris in the 4th quarter valued at about $96,648,000. William Blair Investment Management LLC purchased a new stake in shares of Steris during the 1st quarter worth approximately $102,859,000. BlackRock Inc. increased its stake in shares of Steris by 10.3% during the 4th quarter. BlackRock Inc. now owns 8,549,361 shares of the medical equipment provider’s stock worth $913,498,000 after purchasing an additional 800,900 shares during the last quarter. Finally, Millennium Management LLC increased its stake in shares of Steris by 1,457.4% during the 4th quarter. Millennium Management LLC now owns 607,474 shares of the medical equipment provider’s stock worth $64,909,000 after purchasing an additional 568,469 shares during the last quarter. Hedge funds and other institutional investors own 83.38% of the company’s stock.

STE has been the topic of a number of research analyst reports. Stephens upped their price target on shares of Steris from $135.00 to $150.00 and gave the company an “overweight” rating in a research report on Wednesday, May 15th. Zacks Investment Research cut shares of Steris from a “hold” rating to a “sell” rating in a research report on Wednesday, April 17th. KeyCorp increased their price objective on shares of Steris from $135.00 to $138.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 15th. Finally, JMP Securities raised their price target on shares of Steris from $135.00 to $150.00 and gave the company a “market outperform” rating in a research report on Wednesday, May 22nd. Five equities research analysts have rated the stock with a buy rating, The stock presently has an average rating of “Buy” and a consensus price target of $148.20.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Further Reading: What is the Beige Book?

Insider Buying and Selling by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.